Stock listing
BOATS:ABUS Arbutus Biopharma Corporation Stock
US listing (BOATS) of Arbutus Biopharma Corporation · home listing NASDAQ:ABUS
Follow Arbutus Biopharma Corporation into a list and get an email when it puts out news.
Home listing price · NASDAQ:ABUS
$4.21 USD -0.07 (-1.6%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ABUS
- Day range
- $4.14 – $4.30 USDOct 30, 2026
- Volume
- 2.53M sharesOct 30, 2026
- Market cap
- $645.3M USDAt the close on Oct 30, 2026 · price × 153.3M shares outstanding
- 52-week range
- $3.50 – $5.45 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $22.99M USDMedian day 3.09M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ABUS · Home | $4.21 USD | -0.07 (-1.6%) | 2,526,174 | $4.28 | $4.305 | $4.141 | $4.28 | Close on Oct 30, 2026 |
| Frankfurt:I9DN | €3.76 EUR | +0.05 (+1.3%) | — | €3.76 | €3.76 | €3.76 | €3.71 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ABUS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.21 | -0.07 | -1.6% | $4.28 | $4.305 | $4.141 | 2,526,174 | |
| $4.28 | -0.04 | -0.9% | $4.34 | $4.38 | $4.23 | 1,209,252 | |
| $4.32 | +0.03 | +0.7% | $4.24 | $4.33 | $4.22 | 1,342,751 | |
| $4.29 | +0.09 | +2.1% | $4.20 | $4.295 | $4.18 | 1,622,666 | |
| $4.20 | 0.00 | 0.0% | $4.22 | $4.26 | $4.18 | 1,405,359 | |
| $4.20 | -0.01 | -0.2% | $4.17 | $4.22 | $4.121 | 2,029,374 | |
| $4.21 | +0.03 | +0.7% | $4.22 | $4.37 | $4.175 | 2,464,177 | |
| $4.18 | -0.15 | -3.5% | $4.32 | $4.35 | $4.17 | 3,025,293 | |
| $4.33 | +0.10 | +2.4% | $4.24 | $4.365 | $4.22 | 2,114,272 | |
| $4.23 | +0.01 | +0.2% | $4.24 | $4.28 | $4.15 | 1,959,273 | |
| $4.22 | -0.07 | -1.6% | $4.29 | $4.29 | $4.18 | 4,541,669 | |
| $4.29 | +0.10 | +2.4% | $4.23 | $4.30 | $4.215 | 2,276,650 | |
| $4.19 | +0.08 | +1.9% | $4.07 | $4.25 | $4.05 | 2,433,901 | |
| $4.11 | -0.04 | -1.0% | $4.13 | $4.155 | $4.05 | 3,481,941 | |
| $4.15 | -0.07 | -1.7% | $4.20 | $4.23 | $4.12 | 2,342,928 | |
| $4.22 | +0.04 | +1.0% | $4.17 | $4.27 | $4.13 | 3,146,214 | |
| $4.18 | -0.11 | -2.6% | $4.22 | $4.30 | $4.05 | 4,854,831 | |
| $4.29 | -0.19 | -4.2% | $4.46 | $4.48 | $4.28 | 4,790,515 | |
| $4.48 | -0.19 | -4.1% | $4.67 | $4.67 | $4.43 | 8,259,928 | |
| $4.67 | +0.22 | +4.9% | $4.45 | $4.80 | $4.41 | 6,183,039 | |
| $4.45 | -0.11 | -2.4% | $4.55 | $4.68 | $4.375 | 8,987,366 | |
| $4.56 | -0.22 | -4.6% | $4.77 | $4.775 | $4.51 | 16,120,400 | |
| $4.78 | +0.09 | +1.9% | $4.675 | $4.95 | $4.675 | 16,876,020 | |
| $4.69 | -0.17 | -3.5% | $4.86 | $4.89 | $4.67 | 17,557,070 | |
| $4.86 | +0.01 | +0.2% | $4.84 | $4.88 | $4.80 | 11,669,570 | |
| $4.85 | -0.03 | -0.6% | $4.89 | $4.93 | $4.84 | 16,881,131 | |
| $4.88 | +0.03 | +0.6% | $4.85 | $4.885 | $4.801 | 6,262,978 | |
| $4.85 | -0.16 | -3.2% | $5.01 | $5.02 | $4.84 | 10,842,010 | |
| $5.01 | +0.01 | +0.2% | $5.02 | $5.05 | $4.995 | 10,494,040 | |
| $5.00 | -0.01 | -0.2% | $5.03 | $5.07 | $4.99 | 4,562,773 | |
| $5.01 | -0.06 | -1.2% | $5.04 | $5.06 | $4.98 | 6,458,529 | |
| $5.07 | +0.02 | +0.4% | $5.10 | $5.10 | $5.04 | 2,715,014 | |
| $5.05 | -0.01 | -0.2% | $5.06 | $5.089 | $5.02 | 4,009,390 | |
| $5.06 | -0.07 | -1.4% | $5.11 | $5.15 | $5.03 | 4,052,465 | |
| $5.13 | +0.01 | +0.2% | $5.12 | $5.16 | $5.095 | 3,803,289 | |
| $5.12 | 0.00 | 0.0% | $5.17 | $5.175 | $5.11 | 1,850,049 | |
| $5.12 | -0.05 | -1.0% | $5.11 | $5.165 | $5.10 | 2,449,553 | |
| $5.17 | -0.01 | -0.2% | $5.16 | $5.23 | $5.125 | 5,507,428 | |
| $5.18 | +0.03 | +0.6% | $5.10 | $5.20 | $5.08 | 5,291,491 | |
| $5.15 | +0.03 | +0.6% | $5.09 | $5.17 | $5.09 | 5,198,303 | |
| $5.12 | +0.02 | +0.4% | $5.11 | $5.154 | $5.095 | 3,226,789 | |
| $5.10 | +0.01 | +0.2% | $5.10 | $5.19 | $5.09 | 2,975,766 | |
| $5.09 | +0.01 | +0.2% | $5.05 | $5.10 | $5.05 | 2,610,125 | |
| $5.08 | +0.01 | +0.2% | $5.05 | $5.105 | $4.992 | 3,562,201 | |
| $5.07 | -0.10 | -1.9% | $5.15 | $5.19 | $5.05 | 4,768,968 | |
| $5.17 | -0.02 | -0.4% | $5.16 | $5.215 | $5.14 | 3,580,023 | |
| $5.19 | -0.01 | -0.2% | $5.19 | $5.23 | $5.175 | 4,596,779 | |
| $5.20 | 0.00 | 0.0% | $5.25 | $5.26 | $5.13 | 8,912,995 | |
| $5.20 | -0.01 | -0.2% | $5.18 | $5.28 | $5.17 | 18,141,090 | |
| $5.21 | +0.44 | +9.2% | $5.20 | $5.45 | $5.09 | 18,070,381 | |
| $4.77 | -0.21 | -4.2% | $4.92 | $4.96 | $4.74 | 1,273,749 | |
| $4.98 | +0.14 | +2.9% | $4.83 | $5.18 | $4.83 | 3,428,246 | |
| $4.84 | +0.13 | +2.8% | $4.79 | $4.85 | $4.645 | 1,446,205 | |
| $4.71 | +0.04 | +0.9% | $4.66 | $4.795 | $4.631 | 1,388,214 | |
| $4.67 | +0.09 | +2.0% | $4.60 | $4.71 | $4.55 | 1,438,732 | |
| $4.58 | -0.01 | -0.2% | $4.56 | $4.65 | $4.505 | 1,390,161 | |
| $4.59 | -0.08 | -1.7% | $4.59 | $4.635 | $4.42 | 1,399,244 | |
| $4.67 | +0.08 | +1.7% | $4.60 | $4.72 | $4.60 | 1,047,786 | |
| $4.59 | -0.04 | -0.9% | $4.59 | $4.665 | $4.545 | 969,215 | |
| $4.63 | +0.09 | +2.0% | $4.57 | $4.65 | $4.53 | 796,104 | |
| $4.54 | -0.08 | -1.7% | $4.57 | $4.64 | $4.45 | 1,265,755 | |
| $4.62 | +0.20 | +4.5% | $4.46 | $4.69 | $4.45 | 1,704,821 | |
| $4.42 | +0.06 | +1.4% | $4.38 | $4.50 | $4.38 | 958,756 | |
| $4.36 | +0.02 | +0.5% | $4.34 | $4.425 | $4.31 | 1,421,329 | |
| $4.34 | -0.07 | -1.6% | $4.40 | $4.45 | $4.27 | 1,167,946 | |
| $4.41 | +0.12 | +2.8% | $4.30 | $4.42 | $4.26 | 786,236 |
- Ticker
- BOATS:ABUS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Latest deck · Dec 11, 2025
Corporate Update (December 2025)
Corporate update · 19 slides
Calls
Replays
Arbutus Biopharma (NASDAQ:ABUS) Q3 2024 Earnings Call
Wed, Nov 06, 2024 · 8:45 AM ET
Watch TranscriptArbutus Biopharma (NASDAQ:ABUS) Q2 2024 Earnings Call
Thu, Aug 01, 2024 · 8:45 AM ET
Watch TranscriptArbutus Biopharma (NASDAQ:ABUS) Q1 2024 Earnings Call
Thu, May 02, 2024 · 8:45 AM ET
Watch Transcript
Latest news
Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Oct 22, 2026
Closed $4.21 (+0.7%) on Oct 22, 2026
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
Oct 1, 2026
Closed $4.56 (-4.6%) on Oct 1, 2026
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
Sep 30, 2026
Closed $4.78 (+1.9%) on Sep 30, 2026
Arbutus Biopharma Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
Aug 24, 2026
Closed $5.20 (-0.2%) on Aug 24, 2026
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
Aug 21, 2026
Closed $5.21 (+9.2%) on Aug 21, 2026
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 12, 2026
Closed $4.59 (-1.7%) on Aug 12, 2026
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
Jul 16, 2026
Closed $4.74 (+3.9%) on Jul 16, 2026
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Closed $4.31 (0.0%) on May 13, 2026
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
Apr 15, 2026
Closed $4.48 (+3.0%) on Apr 15, 2026
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Mar 23, 2026
Closed $4.42 (+4.2%) on Mar 23, 2026
Decks
Corporate Update (December 2025)
Corporate update · 19 slides · Dec 11, 2025
Investor Presentation (November 2025)
Investor deck · 32 slides · Nov 13, 2025
Investor Presentation (January 2025)
Investor deck · 22 slides · Jan 13, 2025
Investor Presentation (November 2024)
Investor deck · 23 slides · Nov 15, 2024
Arbutus Biopharma Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 156 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest Nov 6, 2024
- Decks
- 54 decks · latest Dec 11, 2025
Where Arbutus Biopharma Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ABUS · Home listing | NASDAQ | United States | USD |
| LS Exchange:A14XMD | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14XMD | Lang & Schwarz | Germany | EUR |
| BOATS:ABUS · This page | BOATS | United States | USD |
| gettex:I9DN | gettex | Germany | EUR |
| LSE:0SGC | LSE | United Kingdom | USD |
| Stuttgart:I9DN | Stuttgart | Germany | EUR |
| Dusseldorf:I9DN | Dusseldorf | Germany | EUR |
| Frankfurt:I9DN | Frankfurt | Germany | EUR |
| Munich:I9DN | Munich | Germany | EUR |
| Tradegate:I9DN | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Arbutus Biopharma Corporation.